J&J's "mixed" performance in 2012 prompted its board to reduce the planned bonus for CEO Alex Gorsky and other senior officers by 10%, the health-care company said.
WSJ.com: What's News US, Wall Street Journal: Home US
Wed, 03/13/2013 - 9:16am
J&J's "mixed" performance in 2012 prompted its board to reduce the planned bonus for CEO Alex Gorsky and other senior officers by 10%, the health-care company said.